TABLE 1

Patient Characteristics

Patient no.	Sex	Age (y)	Pathology	Indication	Clinical symptoms^*	Confirmation^†
1	M	49	Paraganglioma	Follow-up	No	Histology
2	F	57	Carcinoid of pancreas	Follow-up	No	CT
3	F	47	Carcinoid of pancreas	Follow-up	Diarrhea	CT
4	M	59	Carcinoid of pancreas	Follow-up	No	CT
5	M	79	Carcinoid of pancreas	Follow-up	No	CT
6	M	48	Carcinoid of pancreas	Follow-up	No	CT
7	M	61	Broncogenic carcinoid	Follow-up	No	CT, NaF
8	M	59	Small bowel carcinoid (gastrinoma)	Staging	Gastritis	CT
9	M	62	Small bowel carcinoid	Staging	Flush	CT, MRI
10	F	66	Small bowel carcinoid	Staging	Diarrhea	CT
11	M	39	Elevation of CgA and NSE	Detection	No	CT, MRI
12	F	28	Elevation of ACTH	Detection	Cushing	Histology, CT
13	F	62	Carcinoid of pancreas	Staging	Flush	Histology, CT
14	F	75	NET unknown primary	Follow-up	No	CT
15	M	45	Carcinoid of pancreas	Staging	Diarrhea	CT
16	F	50	NET unknown primary	Follow-up	No	CT
17	F	70	Carcinoid of pancreas	Follow-up	Diarrhea	CT
18	F	61	Elevation of CgA and NSE	Detection	No	Histology
19	F	68	NET unknown primary (gastrinoma)	Staging	Flush	CT
20	M	55	Small bowel carcinoid	Follow-up	No	CT, MRI
21	F	40	NET of hypophysis	Staging	No	MRI
22	M	61	NET unknown primary	Staging	No	MRI, NaF
23	M	61	Carcinoid of pancreas	Staging	No	CT
24	F	54	Carcinoid of pancreas	Follow-up	No	CT
25	M	55	Carcinoid of pancreas (gastrinoma)	Staging	Gastritis	CT
26	F	64	NET unknown primary	Staging	No	CT
27	F	56	NET unknown primary	Follow-up	No	CT, MRI
28	F	57	Hypoglycemia	Detection	NGP and CCR	Histology
29	F	41	Carcinoid of pancreas	Staging	No	CT
30	M	73	Elevation of CgA and NSE	Detection	Diarrhea	MRI, histology
31	M	75	Hypoglycemia	Detection	NGP and CCR	MRI
32	M	51	Carcinoid of stomach	Staging	No	CT
33	F	58	NET unknown primary	Follow-up	Flush, diarrhea	CT
34	M	63	Elevation of CgA and NSE	Detection	Diarrhea	CT, MRI
35	M	62	Small bowel carcinoid	Staging	No	CT
36	F	47	NET unknown primary	Staging	No	CT, histology
37	F	28	Elevation of CgA and NSE	Detection	No	Histology
38	F	41	Broncogenic carcinoid	Follow-up	No	CT
39	M	51	Carcinoid of pancreas	Staging	Diarrhea	CT
40	F	40	Elevation of CgA and NSE	Detection	No	Histology
41	M	77	NET of prostate gland	Staging	No	CT, NaF
42	M	54	Hypoglycemia	Detection	NGP and CCR	CT, MRI
43	M	69	Carcinoid of stomach	Staging	No	CT
44	M	64	Carcinoid of pancreas	Staging	No	CT
45	M	84	Carcinoid of pancreas	Staging	Flush	CT, MRI
46	M	74	NET unknown primary	Staging	No	CT
47	M	74	Broncogenic carcinoid	Staging	No	CT
48	F	43	Carcinoid of pancreas	Staging	No	CT, MRI
49	M	56	Small bowel carcinoid	Staging	No	CT
50	F	57	Small bowel carcinoid	Staging	No	CT, NaF
51	F	58	Small bowel carcinoid	Staging	Flush	CT
52	M	55	Elevation of CgA and NSE	Detection	No	Histology
53	F	51	Elevation of gastrin	Detection	Gastritis	CT, MRI, biopsy
54	M	62	Broncogenic carcinoid	Follow-up	No	CT, MRI
55	M	40	Carcinoid of pancreas (VIPoma)	Staging	Diarrhea	CT, NaF
56	F	67	Small bowel carcinoid	Follow-up	No	CT
57	F	76	Carcinoid of stomach	Staging	Diarrhea	CT, NaF
58	M	34	Carcinoid of pancreas	Follow-up	No	CT, NaF
59	M	66	Small bowel carcinoid	Staging	No	CT
60	M	64	Small bowel carcinoid	Follow-up	No	CT
61	M	58	Small bowel carcinoid	Follow-up	Flush, diarrhea	CT
62	M	59	Small bowel carcinoid	Staging	No	CT
63	F	75	Small bowel carcinoid	Staging	No	CT, MRI
64	M	47	Small bowel carcinoid	Follow-up	No	CT
65	F	61	Broncogenic carcinoid	Follow-up	No	CT, MRI
66	M	62	Small bowel carcinoid	Staging	No	CT
67	M	35	Carcinoid of middle ear	Follow-up	No	CT, MRI
68	M	65	Carcinoid of cecum	Follow-up	Flush	CT
69	M	62	Small bowel carcinoid	Follow-up	Diarrhea	CT
70	M	50	Small bowel carcinoid	Staging	No	CT
71	F	78	Small bowel carcinoid	Follow-up	No	CT, NaF
72	F	37	Hypoglycemia	Detection	NGP and CCR	CT, MRI
73	M	73	Paraganglioma	Follow-up	No	CT, MRI
74	M	79	Carcinoid of rectum	Staging	No	CT
75	F	64	Carcinoid of stomach	Follow-up	No	CT
76	F	66	Broncogenic carcinoid	Follow-up	No	CT
77	F	60	Small bowel carcinoid	Follow-up	Diarrhea	CT
78	M	67	Carcinoid of rectum	Follow-up	No	CT
79	M	69	Paraganglioma	Staging	No	MRI, histology
80	F	47	Small bowel carcinoid	Follow-up	No	CT, MRI, histology
81	F	59	Carcinoid of pancreas	Follow-up	No	CT, NaF
82	M	59	Carcinoid of pancreas	Staging	No	CT, MRI, NaF
83	M	65	Small bowel carcinoid	Follow-up	No	CT
84	M	54	Small bowel carcinoid	Follow-up	No	CT

↵* NGP and CCR = symptoms of neuroglycopenia and catecholamine response.
↵† NaF = ¹⁸F-Na-fluoride PET.
CgA = chromogranin A; NSE = neuron-specific enolase; ACTH = adrenocorticotropic hormone; VIPoma = vasoactive intestinal peptide-producing tumor.